Skip to main content
. Author manuscript; available in PMC: 2012 Dec 5.
Published in final edited form as: J Clin Exp Cardiolog. 2011 Dec 22;2(172):1000172. doi: 10.4172/2155-9880.1000172

Figure 1. 4F administration reduces plasma levels of inflammatory mediators.

Figure 1

Plasma was collected from rats 24 hrs after treatment with vehicle, LPS or LPS+4F for measurement of pro-inflammatory molecules. Units are pg/ml. *denotes a significant difference (P<0.05) compared to vehicle and 4F treated rats. N=5 for each treatment group.